breast-cancer-and-cancer-science-2019-posters-abstracts

Page 32

J Can Res Metastasis, Volume 3

September 16-17, 2019 | Edinburgh, Scotland

Volume 3

Breast Cancer 2019 & Cancer Science 2019

September 16-17, 2019

Journal of Cancer & Metastasis Research

BREAST CANCER

CANCER SCIENCE AND THERAPY

World Congress on

Epidemiology and clinical features of breast cancer in Rwanda

Kalinijabo Yves

College of Science and Technology, Rwanda

Background and Objectives

: Breast cancer is a growing crisis in the developing world. With a majority of breast cancer deaths

occurring in the low income countries including Rwanda. The objective of this analytical study is to assess the epidemiology and

clinical features of breast cancer in Rwanda.

Methods

: Data were collected fromAugust 2015 to January 2017 by considering information recorded fromOut Patients Department

(OPD), surgery and laboratory log books and from the archives of patients tested and diagnosed with breast cancer from three referral

hospitals. Microsoft Excel and Statistical Packages for Social Sciences (SPSS 19.0) have been used for data entry and analysis.

Results

: Brest cancer incidence rate frequency fromAugust 2015 to January 2017 was 33.33% per semester. Amid the diagnosed

breast cancer cases in that period, 97.04% of all cases arise in female whereas 2.87% arise in male. The most frequent breast

cancer type was invasive ductal carcinoma with 80.43% and the least common were mucinous carcinoma and infiltrating

medullary carcinoma with 1.08% for each. According to the age, both male and female between 51 and 60 years old are more

likely to be affected with a frequency of 31.73%.

Discussion and Conclusion

: Breast cancer frequency is increasing, because patients do not go for diagnosis and the few patients

who go for it, are late and breast cancer is already advanced. Therefore we recommend to increase the awareness of breast cancer

but also further researches to find affordable ways of breast cancer detection at early stages, for example we have started a

research on rapid tests for breast cancer detection.